0 comments / 0 votes

Lactiga Therapeutics, an early-stage biotechnology company focused on improving the quality of life of patients with primary immunodeficiency diseases, announced this week that it has oversubscribed its pre-seed financing, raising $1.6 million in new capital including over $350,000 in research grants (including the SOPHIE program run by Innovation Factory). The lead investor in the financing […]

0 comments / 0 votes
0 comments / 0 votes

Thursday, October 6, 2022, from 10:00 am to 12:00 pm in Hamilton, Ontario Mitchel Sivilotti, President of OmniaBio, and Dr. Michael May, President and CEO of CCRM, invite you to attend OmniaBio’s groundbreaking and signing ceremony. OmniaBio will be Canada’s first and largest commercial-scale contract development and manufacturing organization (CDMO) dedicated to cell and gene therapies. […]

0 comments / 0 votes

Archives

> <
Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec